Medtronic 2016 Annual Report Download - page 6

Download and view the complete annual report

Please find page 6 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 158

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158

Table of Contents
3
patients. Our next-generation recapturable TCV system, CoreValve Evolut R, has received U.S. FDA approval and CE Mark
approval for the 23, 26, and 29 millimeter sizes of the valve.
Percutaneous Coronary Intervention (PCI) Our latest generation PCI stent products include our Resolute Integrity drug-eluting
stent systems, which have received U.S. FDA approval, as well as Resolute Onyx drug-eluting stent systems, which have received
CE Mark approval.
Heart Surgery We offer a complete line of surgical valve replacement and repair products for damaged or diseased heart valves.
Our replacement products include both tissue and mechanical valves. We also offer a complete line of blood-handling products
that form a circulatory support system to maintain and monitor blood circulation and coagulation status, oxygen supply, and body
temperature during arrested heart surgery. Additionally, we offer surgical ablation systems and positioning and stabilization
technologies.
Aortic & Peripheral Vascular Disease Management (APV)
Our APV division is comprised of a comprehensive line of products and therapies to treat aortic disease (such as aneurysms,
dissections, and transections) as well as peripheral vascular disease (PVD), and critical limb ischemia (CLI). Our products include
endovascular stent graft systems, peripheral drug coated balloon, stent and angioplasty systems, and carotid embolic protection
systems for the treatment of vascular disease outside the heart, as well as products for superficial and deep venous disease.
The following are the principal products offered by our APV division:
Endovascular Stent Grafts (Aortic) Our products are designed to treat aortic aneurysms in either the abdomen or thoracic regions
of the aorta. Our product line includes a range of endovascular stent grafts and accessories including the market-leading Endurant
2S Abdominal Aortic Aneurysm (AAA) Stent Graft System and the Valiant Captivia Thoracic Aortic Aneurysm (TAA) stent graft
system and the Aptus endo anchors.
Peripheral Vascular Intervention (PVI) Our primary PVI products include percutaneous angioplasty balloons including the
IN.PACT family of drug-coated balloons, which have U.S. FDA and CE Mark approval, as well as peripheral stents such as the
Protégé & Complete Self Expanding Vascular Stents, the Visi-Pro & Assurant Cobalt Balloon Expandable stents and directional
atherectomy products such as the TurboHawk plaque excision system, and other procedure support products.
EndoVenous (EV) Our EndoVenous product lines are used to treat superficial and deep venous diseases in the lower extremities
and include the Closure Fast RF ablation system, the VenaSeal medical adhesive system while also now focusing on embolisms
with the Concerto detachable coil system, Micro Vascular Plug (MVP), the PV ONYX liquid embolic system and other procedure
support products.
MINIMALLY INVASIVE THERAPIES GROUP
Surgical Solutions
Surgical Solutions develops, manufactures, and markets advanced surgical, general surgical, and hernia products and therapies to
treat diseases and conditions that are typically, but not exclusively, addressed by surgeons. In addition, we develop, manufacture,
and market several unique products in the emerging fields of minimally invasive gastrointestinal diagnostics, ablation, and
interventional lung.
The following are the principal products offered by our Surgical Solutions division:
Surgical Innovations This business includes sales of stapling, vessel sealing, fixation (hernia mechanical devices), mesh, hardware
and surgical instruments, as well as wound closure, and electrosurgical products. Key advanced surgical products include: the Tri-
Staple technology platform for endoscopic stapling, including the Endo GIA reloads and reinforced reloads with Tri-Staple
Technology and the Endo GIA ultra universal stapler; the iDrive and Signia powered stapling systems; the LigaSure vessel sealing
system, which features specialty/application specific handpieces powered by proprietary hardware platforms; the Sonicision
cordless ultrasonic dissection system; AbsorbaTack absorbable mesh fixation device for hernia repair; Symbotex composite mesh
for surgical laparoscopic and open ventral hernia repair; and Parietex ProGrip, a selfgripping, biocompatible solution for inguinal
hernias.
Early Technologies Our products include ablation products, and interventional lung and gastrointestinal solutions. This includes
the PillCam SB and PillCam COLON, a minimally-invasive, swallowed optical endoscopy technology; superDimesion to evaluate
lung lesions; the Cool-tip radiofrequency ablation system; the Evident microwave ablation system; and the HALO ablation catheters
for treatment of Barrett’s esophagus.